NGL FINECHEM
Back to All Ratios
|
NGL FINECHEM Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/CE(x) | 4.46 | 2.98 | 4.47 | 4.62 | 1.18 |
What is the latest EV/CE ratio of NGL FINECHEM ?
Year | EV/CE |
---|---|
Mar2024 | 4.46 |
Mar2023 | 2.98 |
Mar2022 | 4.47 |
Mar2021 | 4.62 |
Mar2020 | 1.18 |
How is EV/CE of NGL FINECHEM Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 4.46 | 49.66 | |
Mar2023 | 2.98 | -33.33 | |
Mar2022 | 4.47 | -3.25 | |
Mar2021 | 4.62 | 291.53 | |
Mar2020 | 1.18 | - |
Other Financial Ratios of NGL FINECHEM
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,174.0 Cr | 0.5% | 3.7% | -5.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹429,361.0 Cr | -1.4% | 1.2% | 46.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,274.0 Cr | -1.4% | 1.8% | 60% | Stock Analytics | |
CIPLA | ₹117,144.0 Cr | -0.3% | -3.3% | 19.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,134.0 Cr | 0.8% | 1.8% | 13.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,554.4 Cr | -1.7% | 1.2% | 53.9% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 0.5% |
3.7% |
-5.7% |
SENSEX | -1% |
3.9% |
16% |
You may also like the below Video Courses